<p><strong>Pediatric patients</strong>: Safety and effectiveness in pediatric patients and adolescents less than 18 years of age have not been established.<br />
<br />
<strong>Geriatric patients</strong>: These patients are at increased risk for developing severe tendon disorders including tendon rupture when being treated with a fluoroquinolone such as Moxifloxacin. This risk is further increased in patients receiving concomitant corticosteroid therapy.</p>